Chris Cargill
Director Ejecutivo en NXERA PHARMA CO., LTD. .
Cargos activos de Chris Cargill
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NXERA PHARMA CO., LTD. | Director/Miembro de la Junta | 24/03/2022 | - |
| Director Ejecutivo | 24/03/2022 | - | |
| Presidente | 24/03/2022 | - | |
| Director Financiero/CFO | 01/06/2018 | 24/03/2022 | |
| Contacto de Relaciones con Inversores | 01/06/2018 | 24/03/2022 | |
| Public Communications Contact | 20/09/2017 | 01/06/2018 | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Director/Miembro de la Junta | 01/06/2018 | - |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Director/Miembro de la Junta | 01/01/2019 | - |
Historial de carrera de Chris Cargill
Formación de Chris Cargill.
| Monash University | Undergraduate Degree |
Estadísticas
Internacional
| Reino Unido | 3 |
| Japón | 2 |
| Australia | 2 |
Operativa
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Director of Finance/CFO | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NXERA PHARMA CO., LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Health Technology |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Chris Cargill
- Experiencia
